S. B. Kim

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong et al. · Annals of Oncology · 2022 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma

Chang Hwan Ryu, Jong‐Lyel Roh, S. B. Kim et al. · Annals of Oncology · 2012 · 29 citations

Medicine, Oncology, Cancer Epidemiology +5

MonarcHER: A randomized phase II study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer (ABC)

SM Tolaney, Andrew Wardley, Stefania Zambelli et al. · Annals of Oncology · 2019 · 24 citations

Medicine, Oncology, Pharmacology +17

Statin therapy is associated with improved survival in incident peritoneal dialysis patients: propensity-matched comparison

Jeong Eon Lee, K.-H. Oh, Kyu Hun Choi et al. · Nephrology Dialysis Transplantation · 2011 · 23 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life

Eric Van Cutsem, Kazuaki Kato, Jaffer A. Ajani et al. · ESMO Open · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +17